Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dynactin associated protein pseudogene 3 (DYNAPP3) is a pseudogene in the human genome, located on chromosome 18[6]. Pseudogenes are genomic sequences resembling known genes but are generally non-functional due to mutations or lack of expression. DYNAPP3 is related by sequence to the functional dynactin associated protein gene (DYNAP), but there is no evidence that DYNAPP3 encodes a protein or contributes to any biological function, disease process, or therapeutic mechanism. No known drugs, mechanisms, or clinical relevance are described for this locus[3][6]. Be cautious not to confuse DYNAPP3 (a pseudogene, non-functional) with DYNAP (dynactin associated protein), which is a protein-coding gene with some described biological roles such as promoting AKT1 signaling and cell proliferation[2][4][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dynactin associated protein pseudogene 3 (DYNAPP3).